Science and Innovation

Scientists Uncover Hidden Immune Signal Key to Spinal Cord Regeneration

New research has revealed that a specific subgroup of immune cells, previously seen as mere 'cleanup crew', play a critical role in coordinating the regenerative process after spinal cord injury, a discovery that could inform future human treatments.

By Brad Burgess | 9 September 2026
Close-up of a surgeon's hands performing an intricate procedure in the operating room.

Scientists have identified a previously unrecognised function of certain immune cells and a key molecular signal that enables spinal cords to regenerate following injury, offering a potential new avenue for treating human spinal cord damage.

The research, led by Professor Thomas Becker and conducted by Xiaobo Tian, focused on neutrophils, a type of immune cell commonly found at injury sites. Neutrophils have long been considered primarily responsible for clearing debris from damaged tissue. However, this new study suggests a more profound role for a specific subgroup of these cells.

According to the findings, these particular neutrophils are crucial for orchestrating the immune response, redirecting it from damaging inflammation towards conditions that actively support tissue regeneration. The central molecule involved in this process is known as Il-4.

To investigate the influence of neutrophils on healing, the international research team studied larval zebrafish. These aquatic creatures possess a remarkable natural ability to regenerate damaged spinal cords, making them an invaluable model for regenerative medicine research. The scientists closely observed the activity of these specific immune cells and the Il-4 signalling molecule at the injury site.

When the researchers selectively inactivated this subgroup of neutrophils, the delicate balance of the immune response was disrupted. Other immune cells began to produce excessive quantities of highly inflammatory proteins, leading to an uncontrolled and destructive reaction. Consequently, the zebrafish exhibited an impaired ability to regrow nerve fibres and experienced significant difficulties in recovering their normal movement.

A dramatic shift in outcome was observed when the scientists directly applied the Il-4 molecule to the injured area. In these instances, inflammation rapidly subsided, and the spinal cords regenerated perfectly, even in the absence of the neutrophils themselves.

Professor Thomas Becker, who led the study, emphasised the significance of these findings. "For the first time, we have shown that neutrophils play a massive, active role in successfully repairing a spinal cord," he stated. "They aren't just there to clear away debris; they act like conductors that tell other immune cells to return to a harmonious rhythm. Without them, the immune system locks into a destructive cycle and prevents healing."

Professor Becker further explained the mechanism: "By using the Il-4 molecule, the neutrophils smooth out the inflammation, allowing the delicate nerve fibres to grow right through the injury zone."

One of the persistent challenges in regenerative medicine is understanding why organisms like zebrafish can fully recover from spinal cord injuries, while humans typically cannot. In humans, the immune response triggered by damage to the central nervous system often contributes to lasting injury and actively hinders the regeneration of damaged nerve tissue.

The insights gained from zebrafish provide a clearer picture of the conditions necessary for successful regeneration. The research reinforces the existing understanding that precise control over inflammation is an essential factor for effective healing. Furthermore, it highlights how specific immune signals, delivered at optimal times, can cultivate an environment conducive to nerve fibre regrowth.

The next critical step for researchers is to ascertain whether a similar biological process might also occur in humans. Xiaobo Tian, who conducted the study, highlighted the potential implications. "Of course, the question is to what extent our results apply to humans," Tian noted. "It remains to be seen if Il-4 plays a similar role in humans and whether it can finely balance the inflammation, allowing for better healing at the injury site."

Despite the need for further research in human physiology, Tian expressed optimism about the discovery's future impact. "It is definitely a very promising avenue for future studies in humans," Tian concluded.

The study was led by Xiaobo Tian and an international team of scientists affiliated with the Center for Regenerative Therapies Dresden (CRTD) at TU Dresden, the Cluster of Excellence Physics of Life, and the Centre for Discovery Brain Sciences at the University of Edinburgh. Funding for the research was provided by the Chinese Scholarship Council and the Alexander-von-Humboldt Foundation.